Arsenal Medical announced late-breaking results from the EMBO-02 first-in-human (FIH) clinical study, which is evaluating the ...
This article is Part Two of a three-part community health series presented in partnership with Southern Kentucky Vascular, Somerset.
While some research has shown benefits for patients who qualify, questions remain about the therapy's long-term risks and use among men without a medical need.
The third-place play-off takes place on Saturday, but why is it held and do players and managers really want to compete in it ...
Senator Lindsey Graham's sudden death has understandably focused public attention on a rare but devastating cardiovascular emergency. Yet beneath the headlines lies an opportunity to correct one of ...
USA-trained neurosurgeon Dr. Rao translates international AVM research into practical guidance, explaining personalized, evidence-based treatment. Every brain AVM is unique. The best treatment isn’t ...
Fluidx Medical Technology, Inc. announced results from a pivotal clinical trial evaluating the company’s GPX embolic device.
Uterine fibroids can make day-to-day living a challenge for many women. While fibroids are common, they are much more common ...
A liquid embolic procedure reduces the need for repeated surgical drainage in elderly patients managing chronic subdural ...
Embolx, Inc., a leader in advanced microcatheter technology for targeted embolization procedures, today announced that the Centers for Medicare & Medicaid Services (CMS) has established a new HCPCS ...
A minimally invasive procedure that targets inflamed blood vessels is giving many people with chronic knee pain lasting ...
Shape Memory Medical Inc., developer of the only commercially available volume‑expanding shape memory polymer for endovascular embolization, announced today that it has completed enrollment in the AAA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results